US 11286305
Complex comprising anti-transferrin receptor antibody covalently linked to an oligonucleotide that targets DUX4 RNA
granted A61KA61K2039/505A61K47/6807
Quick answer
US patent 11286305 (Complex comprising anti-transferrin receptor antibody covalently linked to an oligonucleotide that targets DUX4 RNA) held by Dyne Therapeutics, Inc. expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Dyne Therapeutics, Inc.
- Grant date
- Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61K47/6807, A61K47/6849, A61K47/6889